This HTML5 document contains 78 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q63832036
rdf:type
wikibase:Item
schema:description
clinical trial klinisch onderzoek клінічне випробування ensayu clínicu
rdfs:label
Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
skos:prefLabel
Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
schema:name
Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
p:P1476
wds:Q63832036-5D6BB455-53D6-4F7E-B061-A6E39C671B55
wdt:P1476
Randomized Phase II Study of Paclitaxel With or Without the Anti-IGF-IR mAb Cixutumumab (IMC-A12) as Second Line Treatment for Patients With Metastatic Esophageal or GE Junction Cancer
p:P582
wds:Q63832036-851FAFD1-CF3E-4832-9DB1-31D50B802779
wdt:P582
2014-07-15T00:00:00Z
p:P31
wds:Q63832036-67E76641-3197-4E2E-B4A0-AE9EE0FBC4DC
wdt:P31
wd:Q30612
p:P580
wds:Q63832036-717514E4-3EA6-4EAA-8ED6-502F38753933
wdt:P580
2010-09-21T00:00:00Z
p:P6153
wds:Q63832036-6AD36226-14CF-4925-ABAA-642AD6D22DF1 wds:Q63832036-6C37858B-243B-4A15-9CF2-0FF42B4D5B70 wds:Q63832036-73BA3D52-15D5-42E6-8B16-214D3527B15B wds:Q63832036-74186155-BB1C-482A-9D30-F2F8BC60D7F8 wds:Q63832036-843A4A09-7617-4D36-A119-1CA5F8A385F2 wds:Q63832036-2715485E-2748-4F1D-B4E5-CCB8E5A7F90D wds:Q63832036-318886BF-312C-4774-95EF-8221619AA200 wds:Q63832036-4671EDD2-D9C7-4BA2-A5C3-3B547B6C0B31 wds:Q63832036-60C878E4-7ABB-4CD1-BE2A-58B3775258C9 wds:Q63832036-615B37A4-307B-4FFB-A0CB-81B6272693E0 wds:Q63832036-09A33B3A-C2FF-4E9D-8051-CBFDB11B0971 wds:Q63832036-FE030F41-318B-4A51-8528-62CE7D0ECD71 wds:Q63832036-D7B969BE-2954-4477-B482-9D9454CD3D0D wds:Q63832036-D9F3C573-C12C-431B-8342-A07F89F6CD14 wds:Q63832036-DD678F11-D97B-4C5C-8464-5206CCE13163 wds:Q63832036-E4068037-A673-4AEF-B3FC-18A00CC82D0B wds:Q63832036-EF8CAE35-4326-4717-8748-AE55C39927F6 wds:Q63832036-F9A6683D-4168-4375-8EFD-66571EEFBB41 wds:Q63832036-89E02761-1AC0-4F69-8F2F-02DCC7E8C662 wds:Q63832036-9E3167B3-A30D-4E06-91FF-B2FA96DCCFB4 wds:Q63832036-9F4BE2A8-CE54-445C-8E3E-24A82D8FBEEA wds:Q63832036-AFD1BE99-5128-4DF4-903C-82187F09821C wds:Q63832036-C97D1C90-1C9C-4B52-BDBA-2D2ACDED48D4
wdt:P6153
wd:Q87932226 wd:Q6815474 wd:Q7016630 wd:Q1130172 wd:Q22033932 wd:Q14716149 wd:Q770544 wd:Q30270451 wd:Q309350 wd:Q5476635 wd:Q7654755 wd:Q30281132 wd:Q30289179 wd:Q193727 wd:Q30280192 wd:Q235034 wd:Q6031854 wd:Q30254005 wd:Q499451 wd:Q2302319 wd:Q5714832 wd:Q3145247 wd:Q4980899
p:P4844
wds:Q63832036-C9249CB2-25C5-4FBC-A4CE-F0C72448C678
wdt:P4844
wd:Q423762
p:P2899
wds:Q63832036-07812D47-6B42-498F-B57B-2C6FD6444F15
wdt:P2899
18
p:P1050
wds:Q63832036-95DD52B9-4F4E-498D-A629-F663595E6B68 wds:Q63832036-FCED2BA7-A34C-4530-B829-FB94ABE45F9C
wdt:P1050
wd:Q356033 wd:Q33525
p:P1132
wds:Q63832036-2390926E-E710-4BAE-97E0-26B00FF00778
wdt:P1132
94
p:P8363
wds:Q63832036-F5BDA820-56B8-424C-9DB3-2508B8F39B65
wdt:P8363
wd:Q78089383
p:P3098
wds:Q63832036-88984DB9-9021-450B-91E0-91A9049E2FAB
wdt:P3098
NCT01142388
p:P6099
wds:Q63832036-D626A65D-9CC0-427B-9FD4-B5C6C8995920
wdt:P6099
wd:Q42824440